{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:02:38Z","timestamp":1791925358946,"version":"4.3.4"},"reference-count":149,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.lpm.2014.03.007","type":"journal-article","created":{"date-parts":[[2014,5,19]],"date-time":"2014-05-19T17:46:33Z","timestamp":1400521593000},"page":"e167-e180","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":151,"special_numbering":"P2","title":["Hydroxychloroquine: A multifaceted treatment in lupus"],"prefix":"10.1016","volume":"43","author":[{"given":"Nathalie","family":"Costedoat-Chalumeau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Dunogu\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Morel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Le Guern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ga\u00eblle","family":"Guettrot-Imbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2014.03.007_bib0005","series-title":"Systemic lupus erythematosus","first-page":"1061","article-title":"Antimalarials and systemic lupus erythematosus","author":"Costedoat-Chalumeau","year":"2010"},{"key":"10.1016\/j.lpm.2014.03.007_bib0010","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1073\/pnas.79.1.175","article-title":"Decrease in macrophage antigen catabolism caused by ammonia and chloroquine is associated with inhibition of antigen presentation to T cells","volume":"79","author":"Ziegler","year":"1982","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.lpm.2014.03.007_bib0015","first-page":"803","article-title":"Selective regulation of cytokine secretion by hydroxychloroquine: inhibition of interleukin 1 alpha (IL-1-alpha) and IL-6 in human monocytes and T cells","volume":"20","author":"Sperber","year":"1993","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2014.03.007_bib0020","first-page":"1069","article-title":"The effect of hydroxychloroquine on alloreactivity and its potential use for graft-versus-host disease","volume":"17","author":"Gilman","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.lpm.2014.03.007_bib0025","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1182\/blood.V95.11.3460","article-title":"Hydroxychloroquine inhibits calcium signals in T cells: a new mechanism to explain its immunomodulatory properties","volume":"95","author":"Goldman","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.lpm.2014.03.007_bib0030","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1365-2249.1995.tb06648.x","article-title":"Chloroquine inhibits T cell proliferation by interfering with IL-2 production and responsiveness","volume":"102","author":"Landewe","year":"1995","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.lpm.2014.03.007_bib0035","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1097\/00007890-199710150-00019","article-title":"Immune suppression by lysosomotropic amines and cyclosporine on T-cell responses to minor and major histocompatibility antigens: does synergy exist?","volume":"64","author":"Schultz","year":"1997","journal-title":"Transplantation"},{"key":"10.1016\/j.lpm.2014.03.007_bib0040","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.4049\/jimmunol.158.4.1872","article-title":"Mechanisms of action of antimalarials in inflammation: induction of apoptosis in human endothelial cells","volume":"158","author":"Potvin","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.lpm.2014.03.007_bib0045","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1093\/infdis\/164.4.830","article-title":"Chloroquine inhibits tumor necrosis factor production by human macrophages in vitro","volume":"164","author":"Picot","year":"1991","journal-title":"J Infect Dis"},{"key":"10.1016\/j.lpm.2014.03.007_bib0050","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.4049\/jimmunol.132.3.1456","article-title":"Quinacrine inhibits the primary but not secondary proliferative response of human cytotoxic T cells to allogeneic non-T cell antigens","volume":"132","author":"Namiuchi","year":"1984","journal-title":"J Immunol"},{"key":"10.1016\/j.lpm.2014.03.007_bib0055","first-page":"55","article-title":"Chloroquine and hydroxychloroquine equally affect tumor necrosis factor-alpha, interleukin 6, and interferon-gamma production by peripheral blood mononuclear cells","volume":"24","author":"van den Borne","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2014.03.007_bib0060","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/ard.58.4.253","article-title":"Hydroxychloroquine treatment for primary Sjogren's syndrome: its effect on salivary and serum inflammatory markers","volume":"58","author":"Tishler","year":"1999","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2014.03.007_bib0065","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0306-3623(97)00269-3","article-title":"Antimalarial drugs inhibit phospholipase A2 activation and induction of interleukin 1beta and tumor necrosis factor alpha in macrophages: implications for their mode of action in rheumatoid arthritis","volume":"30","author":"Bondeson","year":"1998","journal-title":"Gen Pharmacol"},{"key":"10.1016\/j.lpm.2014.03.007_bib0070","doi-asserted-by":"crossref","first-page":"766","DOI":"10.6061\/clinics\/2013(06)07","article-title":"Hydroxychloroquine decreases Th17-related cytokines in systemic lupus erythematosus and rheumatoid arthritis patients","volume":"68","author":"da Silva","year":"2013","journal-title":"Clinics"},{"key":"10.1016\/j.lpm.2014.03.007_bib0075","doi-asserted-by":"crossref","first-page":"R155","DOI":"10.1186\/ar3895","article-title":"Hydroxychloroquine is associated with impaired interferon-alpha and tumor necrosis factor-alpha production by plasmacytoid dendritic cells in systemic lupus erythematosus","volume":"14","author":"Sacre","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.lpm.2014.03.007_bib0080","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1177\/0961203312437270","article-title":"Effect of hydroxychloroquine treatment on pro-inflammatory cytokines and disease activity in SLE patients: data from LUMINA (LXXV), a multiethnic US cohort","volume":"21","author":"Willis","year":"2012","journal-title":"Lupus"},{"key":"10.1016\/j.lpm.2014.03.007_bib0085","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1038\/sj.onc.1206622","article-title":"Mitochondrial membrane permeabilization is a critical step of lysosome-initiated apoptosis induced by hydroxychloroquine","volume":"22","author":"Boya","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.lpm.2014.03.007_bib0090","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1080\/10428190290021506","article-title":"Hydroxychloroquine-induced apoptosis of chronic lymphocytic leukemia involves activation of caspase-3 and modulation of Bcl-2\/bax\/ratio","volume":"43","author":"Lagneaux","year":"2002","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.lpm.2014.03.007_bib0095","doi-asserted-by":"crossref","first-page":"6914","DOI":"10.4049\/jimmunol.166.11.6914","article-title":"Western and Chinese antirheumatic drug-induced T cell apoptotic DNA damage uses different caspase cascades and is independent of Fas\/Fas ligand interaction","volume":"166","author":"Lai","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.lpm.2014.03.007_bib0100","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/art.1780400522","article-title":"Induction of apoptosis in peripheral blood lymphocytes following treatment in vitro with hydroxychloroquine","volume":"40","author":"Meng","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2014.03.007_bib0105","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2249.2006.03070.x","article-title":"Hydroxychloroquine potentiates Fas-mediated apoptosis of rheumatoid synoviocytes","volume":"144","author":"Kim","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.lpm.2014.03.007_bib0110","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1067\/mai.2001.116004","article-title":"Hydroxychloroquine sulphate inhibits in vitro apoptosis of circulating lymphocytes in patients with systemic lupus erythematosus","volume":"19","author":"Liu","year":"2001","journal-title":"Asian Pac J Allergy Immunol"},{"key":"10.1016\/j.lpm.2014.03.007_bib0115","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1073\/pnas.54.2.521","article-title":"Inhibition of DNA and RNA polymerase reactions by chloroquine","volume":"54","author":"Cohen","year":"1965","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.lpm.2014.03.007_bib0120","first-page":"113","article-title":"Ca2+-antagonistic properties of phospholipase A2 inhibitors, mepacrine and chloroquine","volume":"8","author":"Filippov","year":"1989","journal-title":"Gen Physiol Biophys"},{"key":"10.1016\/j.lpm.2014.03.007_bib0125","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1002\/art.22157","article-title":"Antimalarial agents: Closing the gate on toll-like receptors?","volume":"54","author":"Lafyatis","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2014.03.007_bib0130","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1002\/art.21273","article-title":"RNA released from necrotic synovial fluid cells activates rheumatoid arthritis synovial fibroblasts via Toll-like receptor 3","volume":"52","author":"Brentano","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2014.03.007_bib0135","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/ncprheum0292","article-title":"Mode of action of hydroxychloroquine in RA-evidence of an inhibitory effect on toll-like receptor signaling","volume":"2","author":"Kyburz","year":"2006","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1016\/j.lpm.2014.03.007_bib0140","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/416603a","article-title":"Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors","volume":"416","author":"Leadbetter","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.lpm.2014.03.007_bib0145","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1002\/art.22156","article-title":"Low blood concentration of hydroxychloroquine is a marker for and predictor of disease exacerbations in patients with systemic lupus erythematosus","volume":"54","author":"Costedoat-Chalumeau","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2014.03.007_bib0150","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1056\/NEJM199101173240303","article-title":"A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus","volume":"324","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2014.03.007_bib0155","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1191\/096120398678919778","article-title":"A long-term study of hydroxychloroquine withdrawal on exacerbations in systemic lupus erythematosus","volume":"7","author":"Tsakonas","year":"1998","journal-title":"Lupus"},{"key":"10.1016\/j.lpm.2014.03.007_bib0160","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1191\/096120301678646137","article-title":"Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study","volume":"10","author":"Levy","year":"2001","journal-title":"Lupus"},{"key":"10.1016\/j.lpm.2014.03.007_bib0165","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/096120339600500313","article-title":"Controlled trial with chloroquine diphosphate in systemic lupus erythematosus","volume":"5","author":"Meinao","year":"1996","journal-title":"Lupus"},{"key":"10.1016\/j.lpm.2014.03.007_bib0170","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s11926-013-0360-0","article-title":"2013 update: Hopkins lupus cohort","volume":"15","author":"Fangtham","year":"2013","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.lpm.2014.03.007_bib0175","article-title":"Predictors of renal insufficiency in systemic lupus erythematosus (abstract)","author":"Petri","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2014.03.007_bib0180","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1191\/0961203306lu2313oa","article-title":"Hydroxychloroquine use predicts complete renal remission within 12 months among patients treated with mycophenolate mofetil therapy for membranous lupus nephritis","volume":"15","author":"Kasitanon","year":"2006","journal-title":"Lupus"},{"key":"10.1016\/j.lpm.2014.03.007_bib0185","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/art.24538","article-title":"Protective effect of hydroxychloroquine on renal damage in patients with lupus nephritis: LXV, data from a multiethnic US cohort","volume":"61","author":"Pons-Estel","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2014.03.007_bib0190","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/acr.21664","article-title":"American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis","volume":"64","author":"Hahn","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.lpm.2014.03.007_bib0195","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1136\/annrheumdis-2012-201940","article-title":"Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR\/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis","volume":"71","author":"Bertsias","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2014.03.007_bib0200","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1177\/0961203307078579","article-title":"Hydroxychloroquine sulfate treatment is associated with later onset of systemic lupus erythematosus","volume":"16","author":"James","year":"2007","journal-title":"Lupus"},{"key":"10.1016\/j.lpm.2014.03.007_bib0205","doi-asserted-by":"crossref","first-page":"4380","DOI":"10.1161\/01.CIR.96.12.4380","article-title":"Hydroxychloroquine reverses thrombogenic properties of antiphospholipid antibodies in mice","volume":"96","author":"Edwards","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.lpm.2014.03.007_bib0210","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3109\/03009749609069986","article-title":"Thrombosis and systemic lupus erythematosus: the Hopkins Lupus Cohort perspective","volume":"25","author":"Petri","year":"1996","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.lpm.2014.03.007_bib0215","first-page":"622","article-title":"Antiphospholipid antibody profiles and their clinical associations in Chinese patients with systemic lupus erythematosus","volume":"32","author":"Mok","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2014.03.007_bib0220","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1177\/0961203306071872","article-title":"Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus","volume":"15","author":"Ruiz-Irastorza","year":"2006","journal-title":"Lupus"},{"key":"10.1016\/j.lpm.2014.03.007_bib0225","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1093\/rheumatology\/kei014","article-title":"Systemic lupus erythematosus in a multiethnic cohort (LUMINA): XXVIII. Factors predictive of thrombotic events","volume":"44","author":"Ho","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.lpm.2014.03.007_bib0230","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/art.24232","article-title":"Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies","volume":"61","author":"Tektonidou","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2014.03.007_bib0235","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1136\/ard.2008.093013","article-title":"Risk and protective factors for thrombosis in systemic lupus erythematosus: results from a large, multi-ethnic cohort","volume":"68","author":"Kaiser","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2014.03.007_bib0240","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/art.27289","article-title":"The protective effect of antimalarial drugs on thrombovascular events in systemic lupus erythematosus","volume":"62","author":"Jung","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2014.03.007_bib0245","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3899\/jrheum.120157","article-title":"Hydroxychloroquine use is associated with lower odds of persistently positive antiphospholipid antibodies and\/or lupus anticoagulant in systemic lupus erythematosus","volume":"40","author":"Broder","year":"2013","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2014.03.007_bib0250","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1177\/0961203312437810","article-title":"APS ACTION\u2013Antiphospholipid syndrome alliance for clinical trials and international networking","volume":"21","author":"Erkan","year":"2012","journal-title":"Lupus"},{"key":"10.1016\/j.lpm.2014.03.007_bib0255","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1182\/blood-2008-03-144204","article-title":"Hydroxychloroquine directly reduces the binding of antiphospholipid antibody-beta2-glycoprotein I complexes to phospholipid bilayers","volume":"112","author":"Rand","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.lpm.2014.03.007_bib0260","first-page":"195","article-title":"Hypoglycemia induced by hydroxychloroquine in a type II diabetic treated for polyarthritis","volume":"26","author":"Shojania","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2014.03.007_bib0265","doi-asserted-by":"crossref","first-page":"678","DOI":"10.7326\/0003-4819-112-9-678","article-title":"Hydroxychloroquine in decompensated, treatment-refractory noninsulin-dependent diabetes mellitus. A new job for an old drug?","volume":"112","author":"Quatraro","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.lpm.2014.03.007_bib0270","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1001\/jama.298.2.187","article-title":"Hydroxychloroquine and risk of diabetes in patients with rheumatoid arthritis","volume":"298","author":"Wasko","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.lpm.2014.03.007_bib0275","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.3899\/jrheum.090994","article-title":"Hydroxychloroquine and glycemia in women with rheumatoid arthritis and systemic lupus erythematosus","volume":"37","author":"Penn","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2014.03.007_bib0280","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1001\/jama.2011.878","article-title":"Association between disease-modifying antirheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasis","volume":"305","author":"Solomon","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.lpm.2014.03.007_bib0285","first-page":"325","article-title":"The cholesterol lowering effect of antimalarial drugs is enhanced in patients with lupus taking corticosteroid drugs","volume":"26","author":"Rahman","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2014.03.007_bib0290","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/0002-9343(94)90151-1","article-title":"Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: a longitudinal data analysis","volume":"96","author":"Petri","year":"1994","journal-title":"Am J Med"},{"key":"10.1016\/j.lpm.2014.03.007_bib0295","first-page":"661","article-title":"The lipid, lipoprotein, and apolipoprotein effects of hydroxychloroquine in patients with systemic lupus erythematosus","volume":"20","author":"Hodis","year":"1993","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2014.03.007_bib0300","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/0002-9343(90)90345-E","article-title":"Cholesterol-lowering effect of hydroxychloroquine in patients with rheumatic disease: reversal of deleterious effects of steroids on lipids","volume":"89","author":"Wallace","year":"1990","journal-title":"Am J Med"},{"key":"10.1016\/j.lpm.2014.03.007_bib0305","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1136\/ard.56.6.374","article-title":"Effect of disease modifying agents on the lipid profiles of patients with rheumatoid arthritis","volume":"56","author":"Munro","year":"1997","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2014.03.007_bib0310","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1177\/0961203312450084","article-title":"Hydroxychloroquine reduces low-density lipoprotein cholesterol levels in systemic lupus erythematosus: a longitudinal evaluation of the lipid-lowering effect","volume":"21","author":"Cairoli","year":"2012","journal-title":"Lupus"},{"key":"10.1016\/j.lpm.2014.03.007_bib0315","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1191\/096120300678828541","article-title":"Hydroxychloroquine has no significant effect on lipids and apolipoproteins in Chinese systemic lupus erythematosus patients with mild or inactive disease","volume":"9","author":"Tam","year":"2000","journal-title":"Lupus"},{"key":"10.1016\/j.lpm.2014.03.007_bib0320","first-page":"780","article-title":"Longterm beneficial effect of chloroquine diphosphate on lipoprotein profile in lupus patients with and without steroid therapy","volume":"28","author":"Borba","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2014.03.007_bib0325","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1007\/BF02535017","article-title":"Inhibition of hepatic cholesterol biosynthesis by chloroquine","volume":"16","author":"Beynen","year":"1981","journal-title":"Lipids"},{"key":"10.1016\/j.lpm.2014.03.007_bib0330","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1194\/jlr.M700056-JLR200","article-title":"Cholesterol efflux via HDL resecretion occurs when cholesterol transport out of the lysosome is impaired","volume":"48","author":"Pagler","year":"2007","journal-title":"J Lipid Res"},{"key":"10.1016\/j.lpm.2014.03.007_bib0335","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1177\/09612033070160040901","article-title":"Chloroquine increases low-density lipoprotein removal from plasma in systemic lupus patients","volume":"16","author":"Sachet","year":"2007","journal-title":"Lupus"},{"key":"10.1016\/j.lpm.2014.03.007_bib0340","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1056\/NEJMoa035471","article-title":"Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus","volume":"349","author":"Roman","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2014.03.007_bib0345","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1191\/0961203305lu2039oa","article-title":"Bone mineral density in postmenopausal Chinese patients with systemic lupus erythematosus","volume":"14","author":"Mok","year":"2005","journal-title":"Lupus"},{"key":"10.1016\/j.lpm.2014.03.007_bib0350","first-page":"102","article-title":"Factors associated with low bone mineral density in female patients with systemic lupus erythematosus","volume":"28","author":"Lakshminarayanan","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2014.03.007_bib0355","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1007\/s00198-012-2157-9","article-title":"Six-year follow-up study of bone mineral density in patients with systemic lupus erythematosus","volume":"24","author":"Jacobs","year":"2013","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.lpm.2014.03.007_bib0360","doi-asserted-by":"crossref","first-page":"337","DOI":"10.7326\/0003-4819-144-5-200603070-00008","article-title":"Adding chloroquine to conventional treatment for glioblastoma multiforme: a randomized, double-blind, placebo-controlled trial","volume":"144","author":"Sotelo","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.lpm.2014.03.007_bib0365","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1097\/CAD.0b013e32832f4e50","article-title":"Hydroxychloroquine, chloroquine, and all-trans retinoic acid regulate growth, survival, and histone acetylation in breast cancer cells","volume":"20","author":"Rahim","year":"2009","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.lpm.2014.03.007_bib0370","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1136\/ard.2006.067777","article-title":"Antimalarials may influence the risk of malignancy in systemic lupus erythematosus","volume":"66","author":"Ruiz-Irastorza","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2014.03.007_bib0375","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S1473-3099(08)70070-7","article-title":"Confronting an influenza pandemic with inexpensive generic agents: can it be done?","volume":"8","author":"Fedson","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.lpm.2014.03.007_bib0380","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ijantimicag.2007.05.015","article-title":"Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century","volume":"30","author":"Rolain","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.lpm.2014.03.007_bib0385","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/jac\/dkt310","article-title":"Treatment of classic Whipple's disease: from in vitro results to clinical outcome","volume":"69","author":"Lagier","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.lpm.2014.03.007_bib0390","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1001\/jama.2012.6936","article-title":"Effects of hydroxychloroquine on immune activation and disease progression among HIV-infected patients not receiving antiretroviral therapy: a randomized controlled trial","volume":"308","author":"Paton","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.lpm.2014.03.007_bib0395","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1191\/0961203302lu203ra","article-title":"Protective effect of hydroxychloroquine in systemic lupus erythematosus. Prospective long-term study of an Israeli cohort","volume":"11","author":"Molad","year":"2002","journal-title":"Lupus"},{"key":"10.1016\/j.lpm.2014.03.007_bib0400","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1002\/art.21039","article-title":"Systemic lupus erythematosus in three ethnic grups: XVI. Assciation of hydroxychloroquine use with reduced risk of damage accrual","volume":"52","author":"Fessler","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2014.03.007_bib0405","doi-asserted-by":"crossref","first-page":"831","DOI":"10.3899\/jrheum.120572","article-title":"The early protective effect of hydroxychloroquine on the risk of cumulative damage in patients with systemic lupus erythematosus","volume":"40","author":"Akhavan","year":"2013","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2014.03.007_bib0410","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/acr.20097","article-title":"Possible protective effect of hydroxychloroquine on delaying the occurrence of integument damage in lupus: LXXI, data from a multiethnic cohort","volume":"62","author":"Pons-Estel","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.lpm.2014.03.007_bib0415","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.1002\/art.34672","article-title":"Predictors of organ damage in systemic lupus erythematosus: the Hopkins lupus cohort","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2014.03.007_bib0420","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1136\/ard.2006.068676","article-title":"Effect of hydroxychloroquine in the survival of patients with systemic lupus erythematosus. data from lumina, a multiethnic us cohort (LUMINAL)","volume":"66","author":"Alarcon","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2014.03.007_bib0425","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/art.27300","article-title":"Antimalarial treatment may have a time-dependent effect on lupus survival: data from a multinational Latin American inception cohort","volume":"62","author":"Shinjo","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2014.03.007_bib0430","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1177\/0961203312445230","article-title":"Predictors of survival in Chinese patients with lupus nephritis","volume":"21","author":"Zheng","year":"2012","journal-title":"Lupus"},{"key":"10.1016\/j.lpm.2014.03.007_bib0435","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.autrev.2013.04.006","article-title":"Letter to the Editor in response to the article \u201cPreventing congenital neonatal heart block in offspring of mothers with anti-SSA\/Ro and SSB\/La antibodies: A review of published literature and registered clinical trials.\u201d by Gleicher N, Elkayam U","volume":"12","author":"Costedoat-Chalumeau","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.lpm.2014.03.007_bib0440","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1136\/ard.2009.119263","article-title":"Evaluation of the risk of anti-SSA\/Ro-SSB\/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquine","volume":"69","author":"Izmirly","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2014.03.007_bib0445","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1161\/CIRCULATIONAHA.111.089268","article-title":"Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA\/Ro-antibody-associated cardiac manifestations of neonatal lupus","volume":"126","author":"Izmirly","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.lpm.2014.03.007_bib0450","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1136\/ard.2008.101766","article-title":"Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review","volume":"69","author":"Ruiz-Irastorza","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2014.03.007_bib0455","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/1529-0131(199804)41:4<744::AID-ART26>3.0.CO;2-F","article-title":"Antimalarial drug-induced aquagenic-type pruritus in patients with lupus","volume":"41","author":"Jimenez-Alonso","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2014.03.007_bib0460","unstructured":"Physician's Desk Reference. http:\/\/www.pdr.net; 2013. [Access 31\/03\/2014)."},{"key":"10.1016\/j.lpm.2014.03.007_bib0465","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1001\/jamadermatol.2013.709","article-title":"Hydroxychloroquine-induced pigmentation in patients with systemic lupus erythematosus: a case-control study","volume":"149","author":"Jallouli","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.lpm.2014.03.007_bib0470","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1136\/ard.57.10.582","article-title":"Long-term effectiveness of antimalarial drugs in rheumatic diseases","volume":"57","author":"Avina-Zubieta","year":"1998","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2014.03.007_bib0475","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1002\/art.10980","article-title":"New American Academy of Ophthalmology recommendations on screening for hydroxychloroquine retinopathy","volume":"48","author":"Marmor","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2014.03.007_bib0480","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1002\/art.1780400817","article-title":"Incidence of hydroxychloroquine retinopathy in 1207 patients in a large multicenter outpatient practice","volume":"40","author":"Levy","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2014.03.007_bib0485","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ophtha.2010.11.017","article-title":"Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy","volume":"118","author":"Marmor","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.lpm.2014.03.007_bib0490","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000094079","article-title":"Cardiomyopathy related to antimalarial therapy with Iillustrative case report","volume":"107","author":"Costedoat-Chalumeau","year":"2006","journal-title":"Cardiology"},{"key":"10.1016\/j.lpm.2014.03.007_bib0495","first-page":"2927","article-title":"Hydroxychloroquine neuromyotoxicity","volume":"27","author":"Stein","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2014.03.007_bib0500","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/mus.880110205","article-title":"Chloroquine myopathy and myasthenia-like syndrome","volume":"11","author":"Sghirlanzoni","year":"1988","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.lpm.2014.03.007_bib0505","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1378\/chest.06-1146","article-title":"Hydroxychloroquine-induced toxic myopathy causing respiratory failure","volume":"131","author":"Siddiqui","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.lpm.2014.03.007_bib0510","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1002\/art.10307","article-title":"Hydroxychloroquine concentration-response relationships in patients with rheumatoid arthritis","volume":"46","author":"Munster","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2014.03.007_bib0515","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1111\/j.1600-0560.2008.01004.x","article-title":"Hydroxychloroquine-induced hyperpigmentation: the staining pattern","volume":"35","author":"Puri","year":"2008","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.lpm.2014.03.007_bib0520","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1002\/art.23652","article-title":"Clinical image: blonde by prescription","volume":"58","author":"Meller","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2014.03.007_bib0525","first-page":"586","article-title":"A case of hydroxychloroquine induced pruritus","volume":"16","author":"Gul","year":"2006","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.lpm.2014.03.007_bib0530","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/978-1-4615-4857-7_32","article-title":"Triggered psoriasis","volume":"455","author":"Wolf","year":"1999","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.lpm.2014.03.007_bib0535","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2165\/00128071-200607040-00006","article-title":"The role of antimalarials in the exacerbation of psoriasis: a systematic review","volume":"7","author":"Herman","year":"2006","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.lpm.2014.03.007_bib0540","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1529-8019.2007.00131.x","article-title":"New concepts in antimalarial use and mode of action in dermatology","volume":"20","author":"Kalia","year":"2007","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.lpm.2014.03.007_bib0545","first-page":"814","article-title":"Desensitization to hydroxychloroquine\u00a0\u2013\u00a0experience of 4 patients","volume":"33","author":"Mates","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2014.03.007_bib0550","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.3899\/jrheum.091453","article-title":"Successful desensitization for hydroxychloroquine anaphylaxis","volume":"37","author":"Donado","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2014.03.007_bib0555","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1001\/archderm.1968.01610080067012","article-title":"Hydroxychloroquine-induced agranulocytosis","volume":"97","author":"Chernof","year":"1968","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.lpm.2014.03.007_bib0560","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1056\/NEJM196708312770924","article-title":"Agranulocytosis and hydroxychloroquine","volume":"277","author":"Propp","year":"1967","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2014.03.007_bib0565","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1002\/art.10150","article-title":"Evidence of transplacental passage of hydroxychloroquine in humans","volume":"46","author":"Costedoat-Chalumeau","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2014.03.007_bib0570","first-page":"1715","article-title":"Hydroxychloroquine in pregnant patients with systemic lupus erythematosus","volume":"23","author":"Parke","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2014.03.007_bib0575","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1136\/ard.55.7.486","article-title":"Hydroxychloroquine and lupus pregnancy: review of a series of 36 cases","volume":"55","author":"Buchanan","year":"1996","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2014.03.007_bib0580","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0140-6736(02)07643-2","article-title":"Antimalarial agents in pregnancy","volume":"359","author":"Motta","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2014.03.007_bib0585","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0140-6736(01)06004-4","article-title":"Ocular toxicity and antenatal exposure to chloroquine or hydroxychloroquine for rheumatic diseases","volume":"358","author":"Klinger","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2014.03.007_bib0590","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1002\/art.22159","article-title":"Hydroxychloroquine in lupus pregnancy","volume":"54","author":"Clowse","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2014.03.007_bib0595","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1002\/art.11304","article-title":"Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: a study of one hundred thirty-three cases compared with a control group","volume":"48","author":"Costedoat-Chalumeau","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2014.03.007_bib0600","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1546-0096-7-9","article-title":"Systematic review of hydroxychloroquine use in pregnant patients with autoimmune diseases","volume":"7","author":"Sperber","year":"2009","journal-title":"Pediatr Rheumatol"},{"key":"10.1016\/j.lpm.2014.03.007_bib0605","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.reprotox.2013.04.005","article-title":"Pregnancy outcome following in utero exposure to hydroxychloroquine: a prospective comparative observational study","volume":"39C","author":"Diav-Citrin","year":"2013","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.lpm.2014.03.007_bib0610","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1002\/art.20648","article-title":"Electroretinograms of children born to mothers treated with hydroxychloroquine during pregnancy and breast-feeding: comment on the article by Costedoat-Chalumeau et al","volume":"50","author":"Cimaz","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2014.03.007_bib0615","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1002\/art.20649","article-title":"Reply","volume":"50","author":"Costedoat-Chalumeau","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2014.03.007_bib0620","first-page":"14","article-title":"Follow-up of infants exposed to hydroxychloroquine given to mothers during pregnancy and lactation","volume":"14","author":"Motta","year":"2004","journal-title":"J Perinatol"},{"key":"10.1016\/j.lpm.2014.03.007_bib0625","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1111\/j.1651-2227.2009.01379.x","article-title":"Visual neurophysiological dysfunction in infants exposed to hydroxychloroquine in utero","volume":"98","author":"Renault","year":"2009","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.lpm.2014.03.007_bib0630","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1651-2227.2009.01523.x","article-title":"Visual neurophysiological dysfunction in infants exposed to hydroxychloroquine in utero","volume":"99","author":"Ingster-Moati","year":"2010","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.lpm.2014.03.007_bib0635","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.3899\/jrheum.110686","article-title":"Ocular toxicity in children exposed in utero to antimalarial drugs: review of the literature","volume":"38","author":"Osadchy","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2014.03.007_bib0640","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1365-2125.1984.tb02358.x","article-title":"Excretion of hydroxychloroquine in human milk","volume":"17","author":"Nation","year":"1984","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.lpm.2014.03.007_bib0645","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/ar1957","article-title":"Anti-inflammatory and immunosuppressive drugs and reproduction","volume":"8","author":"Ostensen","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.lpm.2014.03.007_bib0650","unstructured":"Micromedex\u00ae Healthcare Series; http:\/\/www.thomsonhc.com\/hcs\/librarian; 2013. [Access 2013]."},{"key":"10.1016\/j.lpm.2014.03.007_bib0655","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1007\/s00415-011-6335-z","article-title":"The association of systemic lupus erythematosus and myasthenia gravis: a series of 17 cases, with a special focus on hydroxychloroquine use and a review of the literature","volume":"259","author":"Jallouli","year":"2012","journal-title":"J Neurol"},{"key":"10.1016\/j.lpm.2014.03.007_bib0660","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s11938-007-0044-9","article-title":"Treatment options in acute porphyria, porphyria cutanea tarda, and erythropoietic protoporphyria","volume":"10","author":"Harper","year":"2007","journal-title":"Curr Treat Options Gastroenterol"},{"key":"10.1016\/j.lpm.2014.03.007_bib0665","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.cgh.2012.08.038","article-title":"Low-dose hydroxychloroquine is as effective as phlebotomy in treatment of patients with porphyria cutanea tarda","volume":"10","author":"Singal","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.lpm.2014.03.007_bib0670","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.berh.2013.07.001","article-title":"Adherence to treatment in systemic lupus erythematosus patients","volume":"27","author":"Costedoat-Chalumeau","year":"2013","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.lpm.2014.03.007_bib0675","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/imj.12100","article-title":"A cross-sectional study of hydroxychloroquine concentrations and effects in people with systemic lupus erythematosus","volume":"43","author":"Carmichael","year":"2013","journal-title":"Intern Med J"},{"key":"10.1016\/j.lpm.2014.03.007_bib0680","first-page":"1874","article-title":"Concentration-effect relationship of hydroxychloroquine in rheumatoid arthritis--a cross sectional study","volume":"20","author":"Tett","year":"1993","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2014.03.007_bib0685","first-page":"1656","article-title":"Concentration-effect relationship of hydroxychloroquine in patients with rheumatoid arthritis--a prospective, dose ranging study","volume":"27","author":"Tett","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2014.03.007_bib0690","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1136\/annrheumdis-2012-202322","article-title":"Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study)","volume":"72","author":"Costedoat-Chalumeau","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2014.03.007_bib0695","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1001\/archdermatol.2011.2558","article-title":"Low blood concentration of hydroxychloroquine in patients with refractory cutaneous lupus erythematosus: a French multicenter prospective study","volume":"148","author":"Frances","year":"2012","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.lpm.2014.03.007_bib0700","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1136\/ard.2006.067835","article-title":"Very low blood Hydroxychloroquine concentrations as an objective marker of poor adherence to treatment in systemic lupus erythematosus","volume":"66","author":"Costedoat-Chalumeau","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2014.03.007_bib0705","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3899\/jrheum.110771","article-title":"Usefulness of cellular text messaging for improving adherence among adolescents and young adults with systemic lupus erythematosus","volume":"39","author":"Ting","year":"2012","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2014.03.007_bib0710","first-page":"S770","article-title":"Hydroxychloroquine levels identify four distinct subsets of systemic lupus erythematosus patients (abstract)","volume":"65","author":"Petri","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2014.03.007_bib0715","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.jemermed.2004.12.011","article-title":"Are 1-2 dangerous? Chloroquine and hydroxychloroquine exposure in toddlers","volume":"28","author":"Smith","year":"2005","journal-title":"J Emerg Med"},{"key":"10.1016\/j.lpm.2014.03.007_bib0720","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1177\/0961203307086643","article-title":"Hydroxychloroquine: the cornerstone of lupus therapy","volume":"17","author":"Ruiz-Irastorza","year":"2008","journal-title":"Lupus"},{"key":"10.1016\/j.lpm.2014.03.007_bib0725","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11926-010-0141-y","article-title":"Use of hydroxychloroquine to prevent thrombosis in systemic lupus erythematosus and in antiphospholipid antibody-positive patients","volume":"13","author":"Petri","year":"2011","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.lpm.2014.03.007_bib0730","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/acr.20002","article-title":"Hydroxychloroquine treatment in a community-based cohort of patients with systemic lupus erythematosus","volume":"62","author":"Schmajuk","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.lpm.2014.03.007_bib0735","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0140-6736(10)61354-2","article-title":"Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial","volume":"377","author":"Navarra","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2014.03.007_bib0740","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1136\/annrheumdis-2012-202760","article-title":"Efficacy and safety of epratuzumab in patients with moderate\/severe active systemic lupus erythematosus: results from EMBLEM, a phase IIb, randomised, double-blind, placebo-controlled, multicentre study","volume":"73","author":"Wallace","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2014.03.007_bib0745","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1136\/annrheumdis-2012-202460","article-title":"Lupuzor\/P140 peptide in patients with systemic lupus erythematosus: a randomised, double-blind, placebo-controlled phase IIb clinical trial","volume":"72","author":"Zimmer","year":"2013","journal-title":"Ann Rheum Dis"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498214001924?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498214001924?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T03:03:57Z","timestamp":1689217437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498214001924"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":149,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0755498214001924"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2014.03.007","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hydroxychloroquine: A multifaceted treatment in lupus","name":"articletitle","label":"Article Title"},{"value":"La Presse M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2014.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2014.03.002","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2014.03.001","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2014.04.002","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2014.05.001","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2014.03.004","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2014.03.009","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2014.04.006","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2014.04.005","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}